Handelsbanken Fonder AB Sells 10,285 Shares of Itron, Inc. $ITRI

Key Points

• Handelsbanken Fonder reduced its Itron stake by 6.9% in the second quarter, selling 10,285 shares and retaining 138,965 shares valued at approximately $12.0 million. Institutional investors collectively own 96.19% of Itron.
• Itron insiders sold 3,822 shares worth about $314,000 over the past 90 days, primarily to cover tax obligations related to vested equity awards.
• Analysts maintain a broadly positive outlook, with a “Moderate Buy” consensus and an average price target of $131.33. Itron also beat quarterly EPS estimates, reporting $1.59 versus the $1.29 consensus, despite a 7.2% year-over-year revenue decline.

Handelsbanken Fonder AB cut its stake in shares of Itron, Inc. (NASDAQ:ITRI - Free Report) by 6.9% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 138,965 shares of the scientific and technical instruments company's stock after selling 10,285 shares during the quarter. Handelsbanken Fonder AB owned 0.31% of Itron worth $12,025,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of ITRI. EverSource Wealth Advisors LLC lifted its position in Itron by 25.3% in the second quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company's stock valued at $53,000 after purchasing an additional 81 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its stake in shares of Itron by 29.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company's stock worth $41,000 after buying an additional 101 shares during the period. Impact Partnership Wealth LLC raised its holdings in Itron by 4.7% during the 1st quarter. Impact Partnership Wealth LLC now owns 2,661 shares of the scientific and technical instruments company's stock valued at $239,000 after buying an additional 119 shares during the last quarter. Xponance LLC raised its holdings in Itron by 3.2% during the 4th quarter. Xponance LLC now owns 3,877 shares of the scientific and technical instruments company's stock valued at $360,000 after buying an additional 120 shares during the last quarter. Finally, Private Trust Co. NA boosted its position in Itron by 112.4% during the 4th quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company's stock valued at $25,000 after buying an additional 145 shares during the period. 96.19% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, SVP John F. Marcolini sold 322 shares of the company's stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $84.37, for a total value of $27,167.14. Following the sale, the senior vice president directly owned 24,689 shares of the company's stock, valued at $2,083,010.93. This represents a 1.29% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Donald L. Reeves III sold 319 shares of the stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total transaction of $26,914.03. Following the completion of the transaction, the senior vice president owned 29,100 shares of the company's stock, valued at approximately $2,455,167. The trade was a 1.08% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders sold 3,822 shares of company stock worth $314,303. 1.77% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

ITRI has been the topic of a number of analyst reports. Raymond James Financial initiated coverage on shares of Itron in a research report on Tuesday, April 21st. They issued an "underperform" rating on the stock. TD Cowen dropped their target price on shares of Itron from $145.00 to $130.00 and set a "buy" rating for the company in a report on Wednesday, April 29th. Weiss Ratings reissued a "hold (c)" rating on shares of Itron in a research note on Wednesday, August 5th. Zacks Research upgraded Itron from a "strong sell" rating to a "hold" rating in a report on Wednesday, July 29th. Finally, Seaport Research Partners reaffirmed a "buy" rating and set a $150.00 price target on shares of Itron in a research report on Wednesday, July 29th. Eight research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Itron has an average rating of "Moderate Buy" and a consensus price target of $131.33.

Itron Trading Up 0.1%

NASDAQ:ITRI opened at $102.72 on Friday. The company has a 50-day moving average price of $88.31 and a 200-day moving average price of $90.11. The stock has a market cap of $4.50 billion, a price-to-earnings ratio of 17.15, a P/E/G ratio of 0.84 and a beta of 1.30. The company has a current ratio of 2.75, a quick ratio of 2.29 and a debt-to-equity ratio of 0.96. Itron, Inc. has a 12 month low of $77.77 and a 12 month high of $142.00.

Itron (NASDAQ:ITRI - Get Free Report) last posted its earnings results on Tuesday, July 28th. The scientific and technical instruments company reported $1.59 earnings per share for the quarter, topping analysts' consensus estimates of $1.29 by $0.30. The firm had revenue of $562.90 million for the quarter, compared to the consensus estimate of $566.34 million. Itron had a return on equity of 19.26% and a net margin of 11.90%.The business's revenue for the quarter was down 7.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.62 EPS. Itron has set its Q3 2026 guidance at 1.500-1.600 EPS and its FY 2026 guidance at 6.300-6.500 EPS. Equities analysts predict that Itron, Inc. will post 6.43 EPS for the current year.

Itron Profile

Itron, Inc NASDAQ: ITRI is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company's offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron's product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

Want to see what other hedge funds are holding ITRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Itron, Inc. (NASDAQ:ITRI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source